Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Globus Medical (NYSE:GMED) in the last three months.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 3 | 3 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 3 | 1 | 0 | 0 |
| 2M Ago | 1 | 0 | 2 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $78.62, a high estimate of $93.00, and a low estimate of $71.00. This current average reflects an increase of 9.19% from the previous average price target of $72.00.
Exploring Analyst Ratings: An In-Depth Overview
A comprehensive examination of how financial experts perceive...
Login or create a forever free account to read this news
Sign up/Log in